Total Return chart Biogen Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-08 pm EST			5-day change	1st Jan Change
180.44 ^USD	-0.47%		-0.91%	+18.00%

Dec. 05	Stoke Therapeutics, Inc. and Biogen Inc. Present Data That Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome	CI
Dec. 05	Stoke Therapeutics and Biogen present data that further support the disease-modifying potential of zorevunersen	RE

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.